( en | de | ru )

 

Disambiguation of "Lagier, Jean-Christophe"

Author of the publication

copydeleteadd this publication to your clipboard
Early treatment of 1061 COVID-19 patients with hydroxychloroquine and azithromycin, Marseille, France

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , and . (2020)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Jean-Christophe Magnan

Jean-Christophe Legrix

Jean-Christophe Legrix

Jean-Christophe Roux

Jean-Christophe Nebel

 

Other publications of authors with the same name

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis, , , , , , , , , and 33 other author(s). Travel Medicine and Infectious Disease, (2020)Clinical Efficacy of Chloroquine derivatives in COVID-19 Infection: Comparative meta-analysis between the Big data and the real world, , , , , , , , , and 4 other author(s). New Microbes and New Infections, (2020)Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID2 19 patients: a systematic review and meta-analysis, , , and . Clinical Microbiology and Infection, (2020)Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France, , , , , , , , , and 27 other author(s). Travel Medicine and Infectious Disease, (2020)Chloroquine and hydroxychloroquine as available weapons to fight COVID-19, , , , and . International Journal of Antimicrobial Agents, 55 (4): 105932 (2020)Early treatment of 1061 COVID-19 patients with hydroxychloroquine and azithromycin, Marseille, France, , , , , , , , , and 27 other author(s). (2020)Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, , , , , , , , , and 8 other author(s). International Journal of Antimicrobial Agents, 56 (1): 105949 (2020)Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study, , , , , , , , , and 19 other author(s). Travel Medicine and Infectious Disease, (2020)This is the second Marseille study.Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France, , , , , , , , , and 27 other author(s). Travel Medicine and Infectious Disease, (2020)Treatment of classic Whipple's disease: from in vitro results to clinical outcome, , , , , and . Journal of Antimicrobial Chemotherapy, 69 (1): 219–227 (2014)